We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.41%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$110B
AUM Growth
+$8.55B
(+8.4%)
Cap. Flow
+$733M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
32.31%
Holding
285
New
9
Increased
94
Reduced
125
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$381M |
| 2 |
AstraZeneca
AZN
|
+$242M |
| 3 |
Citigroup
C
|
+$201M |
| 4 |
Bath & Body Works
BBWI
|
+$145M |
| 5 |
Hewlett Packard
HPE
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$160M |
| 3 |
Amgen
AMGN
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$146M |
| 5 |
Medtronic
MDT
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 23.76% |
| 3 | Industrials | 15.73% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Financials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
176
DELISTED
Paramount Global Class B
PARA
| $41.5M | 0.04% |
597,600
+327,600
| +121% | +$21.5M |
|
177
Marriott International
MAR
$96.1B
| $41.1M | 0.04% |
436,500
+49,500
| +13% | +$4.3M |
|
178
NOV
NOV
$7.22B
| $40.6M | 0.04% |
1,011,995
+3,000
| +0.3% | +$117K |
|
179
Hilton Worldwide
HLT
$72.9B
| $40.2M | 0.04% |
687,464
+176,331
| +34% | +$10.2M |
|
|
DD
180
DELISTED
Du Pont De Nemours E I
DD
| $38.2M | 0.03% |
475,700
-800
| -0.2% | -$62.1K |
|
|
MNTA
181
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $36.6M | 0.03% |
2,739,900
| – | – |
|
182
Mastercard
MA
$469B
| $35.4M | 0.03% |
314,800
+185,000
| +143% | +$20.3M |
|
183
HubSpot
HUBS
$9.73B
| $34.8M | 0.03% |
574,850
+37,750
| +7% | +$2.14M |
|
184
Cerus
CERS
$575M
| $34.7M | 0.03% |
7,800,000
| – | – |
|
185
Tyson Foods
TSN
$20B
| $32.8M | 0.03% |
531,100
+10,000
| +2% | +$630K |
|
186
Norfolk Southern
NSC
$78.3B
| $30.8M | 0.03% |
275,000
| – | – |
|
187
Stryker
SYK
$122B
| $30.1M | 0.03% |
228,400
| – | – |
|
|
HA
188
DELISTED
Hawaiian Holdings, Inc.
HA
| $29.8M | 0.03% |
641,300
| – | – |
|
189
OSI Systems
OSIS
$3.53B
| $29.4M | 0.03% |
402,800
+40,500
| +11% | +$3.01M |
|
190
TransDigm Group
TDG
$67.9B
| $29.2M | 0.03% |
132,500
+22,300
| +20% | +$5.32M |
|
|
GUID
191
DELISTED
Guidance Software, Inc.
GUID
| $28.2M | 0.03% |
4,779,594
+117,979
| +3% | +$805K |
|
192
Accuray
ARAY
$28.3M
| $26.2M | 0.02% |
5,512,800
-500
| -0% | -$2.6K |
|
193
Standard BioTools
LAB
$343M
| $24.4M | 0.02% |
4,294,843
-689
| -0% | -$4.37K |
|
194
Bank of America
BAC
$430B
| $23.9M | 0.02% |
+1,012,200
| New | +$24M |
|
|
DBD
195
DELISTED
Diebold Nixdorf Incorporated
DBD
| $23.6M | 0.02% |
770,000
| – | – |
|
196
CNA Financial
CNA
$14.1B
| $21.9M | 0.02% |
495,300
-8,400
| -2% | -$358K |
|
|
CIR
197
DELISTED
CIRCOR International, Inc
CIR
| $21.8M | 0.02% |
366,500
-2,500
| -0.7% | -$154K |
|
198
Celanese
CE
$5.19B
| $19M | 0.02% |
211,900
-48,200
| -19% | -$4.21M |
|
|
CUDA
199
DELISTED
Barracuda Networks, Inc.
CUDA
| $18.8M | 0.02% |
815,000
-10,000
| -1% | -$234K |
|
200
Herc Holdings
HRI
$5.45B
| $18.6M | 0.02% |
379,440
+9,448
| +3% | +$444K |
|
Similar funds
Primecap Management's Q1 2017 Portfolio in Review
As of Q1 2017, Primecap Management held 285 positions worth $110B, up 8.4% from $102B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2017: portfolio turnover was 4.2%. Primecap Management opened 9 new positions and exited 3, leaving the 285-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,741,094 shares worth $422M.
- Primecap Management added most to AstraZeneca in Q1 2017, an estimated $242M increase.
- Primecap Management's biggest Q1 2017 reduction was Intel, cutting an estimated $267M.
- Primecap Management fully exited C.H. Robinson in Q1 2017, selling an estimated $14.4M.
- Primecap Management's ten largest holdings make up 32% of its $110B portfolio in Q1 2017.
- Primecap Management opened 9 new positions and closed 3 in Q1 2017.
- Primecap Management's portfolio value rose 8.4% quarter-over-quarter to $110B.
Based on Primecap Management's 13F filing for Q1 2017, filed 12 May 2017.